#Obesity #nutrition & health inequities scientist & registered dietitian • #SciComm #DigitalHealth #Equity advocate • mom • 🇵🇷 • She/ella/Dr • Opinions own
Gainesville, FL
Joined March 2011
- Tweets14K
- Following1.3K
- Followers11.4K
- Likes35K
Pinned Tweet
9 million US adolescents have obesity & deserve the scientific rigor & quality of care, including lifelong treatment, afforded to other chronic diseases. Thanks @JAMA_current @ehlJAMA for the opportunity to publish our piece on treating Adolescent Obesity ja.ma/2o34uMc
Michelle Cardel, PhD, MS, RD retweeted
Just happened at #ADA2026 - personal statement from the one and only Dr John Buse. Definitely worth the watch.
You may have seen the news that the FDA has banned Red No. 3 from foods and medications. What does this mean for you?
Red No. 3 is a synthetic food dye that imparts a red color to foods and beverages.
It’s been commonly used in food products like candy, cakes, cupcakes, cookies, frozen desserts, frosting, icing, and certain orally ingested drugs.
What this means:
Manufacturers who use FD&C Red No. 3 in food products and orally ingested drugs must reformulate their products by January 15, 2027 and January 18, 2028, respectively.
While other countries may still permit certain uses of FD&C Red No. 3, any foods imported into the U.S. must comply with U.S. regulations.
The FDA isn't perfect but this underscores the FDA’s commitment to continuously reviewing safety data and demonstrates the effectiveness of our regulatory agencies in taking action, even when the risk to humans is minimal. This provides assurance that as more data emerges that is concerning about certain food products, that the FDA will do its due diligence to remove potentially harmful products from our grocery store shelves.
Michelle Cardel, PhD, MS, RD retweeted
Read my new year’s testimonial for WeightWatchers: scottholleran.substack.com/p…
Our newest paper, Adolescent experiences of weight related communication: Sociodemographic differences and the role of parents, has been published in Pediatric.
Read the full article here:onlinelibrary.wiley.com/doi/…
Michelle Cardel, PhD, MS, RD retweeted
Big news for beans🌱
As part of the '25 US Dietary Advisory Committee, we recommended putting beans, peas, & lentils at the top of MyPlate's protein section instead of meat.
Why? They have protein, fiber, and no saturated fat.
Small swap, big impact!
cnn.com/2024/12/12/health/be…
Michelle Cardel, PhD, MS, RD retweeted
As the year comes to a close, we'd like to acknowledge the most downloaded papers from 2024.
This article was the second most downloaded article of the year with 405 downloads.
@drfaithhh_anne @MichelleCardel
liebertpub.com/doi/full/10.1…
Michelle Cardel, PhD, MS, RD retweeted
So interesting!
“…nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication initiation.” 🍺
Our newest research from @ww_us Clinic where we assessed changes in alcohol consumption across a variety of anti-obesity medications was covered on @NPR today.
Kudos to Lisa Miller-Matero who was first author and featured in this episode as well, as well as other co-authors including @RebeccaAntonie @DrNadolsky @DrGaryFoster, Hsueh-Han, and Lisiyu Ma.
Link to publication in JAMA Network Open: jamanetwork.com/journals/jam…
npr.org/sections/shots-healt…
Michelle Cardel, PhD, MS, RD retweeted
Since everyone is concerned with the side effects of GLP1s - I'll share this from @MichelleCardel so we can add a little variety to conversation. Kinda feels like a nice break from the usual arguments 😅 – at Brooklyn, NY
Our newest research from @ww_us Clinic where we assessed changes in alcohol consumption across a variety of anti-obesity medications was covered on @NPR today.
Kudos to Lisa Miller-Matero who was first author and featured in this episode as well, as well as other co-authors including @RebeccaAntonie @DrNadolsky @DrGaryFoster, Hsueh-Han, and Lisiyu Ma.
Link to publication in JAMA Network Open: jamanetwork.com/journals/jam…
npr.org/sections/shots-healt…
Our newest research from @ww_us Clinic where we assessed changes in alcohol consumption across a variety of anti-obesity medications was covered on @NPR today.
Kudos to Lisa Miller-Matero who was first author and featured in this episode as well, as well as other co-authors including @RebeccaAntonie @DrNadolsky @DrGaryFoster, Hsueh-Han, and Lisiyu Ma.
Link to publication in JAMA Network Open: jamanetwork.com/journals/jam…
npr.org/sections/shots-healt…
Our newest publication is out in @JAMANetworkOpen showing that patients on a variety of anti-obesity medications (not just GLP1s) decreased their alcohol consumption. A thread 🧵👇🏾
